Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL-Reference-Cited by-同舟云学术

Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL

Published:2001-07 Issue:2-3 Volume:79 Page:99-102
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. The losartan renal protection study – rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan);Brenner;J Renin Angioitens Aldo System,2000

2. www.theheart.org (accessed June 12, 2001).

3. Omapatrilat – the ups and downs of an exciting but complicated new drug;Coats;Int. J Cardiol,2000

4. www.bms.com (accessed June 12, 2001).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension;Wiley Handbook of Current and Emerging Drug Therapies;2006-10-13

2. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a β-blocker);International Journal of Cardiology;2004-02

3. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: A review of the clinical trial evidence;Clinical Therapeutics;2003-12

4. International Journal of Cardiology—the next 5 years;International Journal of Cardiology;2003-12

5. Treatment of Hypertension in African Americans;The Kidney and Hypertension;2003-11-28